Bar J - Search Results

1

The interaction of CD4⁺ helper T cells with dendritic cells shapes the tumor microenvironment and immune checkpoint blockade response.

Cohen M, Giladi A, Barboy O, Hamon P, Li B, Zada M, Gurevich-Shapiro A, Beccaria CG, David E, Maier BB, Buckup M, Kamer I, Deczkowska A, Le Berichel J, Bar J, Iannacone M, Tanay A, Merad M, Amit I. Cohen M, et al. Among authors: bar j. Nat Cancer. 2022 Mar;3(3):303-317. doi: 10.1038/s43018-022-00338-5. Epub 2022 Mar 3. Nat Cancer. 2022. PMID: 35241835

2

Regulation of the inflammatory profile of stromal cells in human breast cancer: prominent roles for TNF-α and the NF-κB pathway.

Katanov C, Lerrer S, Liubomirski Y, Leider-Trejo L, Meshel T, Bar J, Feniger-Barish R, Kamer I, Soria-Artzi G, Kahani H, Banerjee D, Ben-Baruch A. Katanov C, et al. Among authors: bar j. Stem Cell Res Ther. 2015 May 1;6(1):87. doi: 10.1186/s13287-015-0080-7. Stem Cell Res Ther. 2015. PMID: 25928089 Free PMC article.

3

Non-Small-cell Lung Cancer Patients With Adenocarcinoma Morphology Have a Better Outcome Compared With Patients Diagnosed With Non-Small-cell Lung Cancer Favor Adenocarcinoma.

Shiran I, Heller E, Jessel S, Kamer I, Daniel-Meshulam I, Navon R, Urban D, Onn A, Bar J. Shiran I, et al. Among authors: bar j. Clin Lung Cancer. 2017 May;18(3):316-323.e1. doi: 10.1016/j.cllc.2017.01.009. Epub 2017 Feb 2. Clin Lung Cancer. 2017. PMID: 28237243

4

Clinical Significance of Pancreatic Atrophy Induced by Immune-Checkpoint Inhibitors: A Case-Control Study.

Eshet Y, Baruch EN, Shapira-Frommer R, Steinberg-Silman Y, Kuznetsov T, Ben-Betzalel G, Daher S, Gluck I, Asher N, Apter S, Schachter J, Bar J, Boursi B, Markel G. Eshet Y, et al. Among authors: bar j. Cancer Immunol Res. 2018 Dec;6(12):1453-1458. doi: 10.1158/2326-6066.CIR-17-0659. Epub 2018 Oct 1. Cancer Immunol Res. 2018. PMID: 30275274

5

Transformation to small cell lung cancer as a mechanism of resistance to immunotherapy in non-small cell lung cancer.

Bar J, Ofek E, Barshack I, Gottfried T, Zadok O, Kamer I, Urban D, Perelman M, Onn A. Bar J, et al. Lung Cancer. 2019 Dec;138:109-115. doi: 10.1016/j.lungcan.2019.09.025. Epub 2019 Oct 1. Lung Cancer. 2019. PMID: 31683093

6

Self-reported sleep quality as prognostic for survival in lung cancer patients.

Gottfried T, Kamer I, Salant I, Urban D, Lawrence YR, Onn A, Bar J. Gottfried T, et al. Among authors: bar j. Cancer Manag Res. 2020 Jan 15;12:313-321. doi: 10.2147/CMAR.S234523. eCollection 2020. Cancer Manag Res. 2020. PMID: 32021445 Free PMC article.

7

Stromal-MDM2 Promotes Lung Cancer Cell Invasion through Tumor-Host Feedback Signaling.

Kamer I, Daniel-Meshulam I, Zadok O, Bab-Dinitz E, Perry G, Feniger-Barish R, Perelman M, Barshack I, Ben-Nun A, Onn A, Bar J. Kamer I, et al. Among authors: bar j. Mol Cancer Res. 2020 Jun;18(6):926-937. doi: 10.1158/1541-7786.MCR-19-0395. Epub 2020 Mar 13. Mol Cancer Res. 2020. PMID: 32169890

8

Predicting brain metastasis in early stage non-small cell lung cancer patients by gene expression profiling.

Kamer I, Steuerman Y, Daniel-Meshulam I, Perry G, Izraeli S, Perelman M, Golan N, Simansky D, Barshack I, Ben Nun A, Gottfried T, Onn A, Gat-Viks I, Bar J. Kamer I, et al. Among authors: bar j. Transl Lung Cancer Res. 2020 Jun;9(3):682-692. doi: 10.21037/tlcr-19-477. Transl Lung Cancer Res. 2020. PMID: 32676330 Free PMC article.

9

Immunotherapy response modeling by ex-vivo organ culture for lung cancer.

Kamer I, Bab-Dinitz E, Zadok O, Ofek E, Gottfried T, Daniel-Meshulam I, Hout-Siloni G, Ben Nun A, Barshack I, Onn A, Bar J. Kamer I, et al. Among authors: bar j. Cancer Immunol Immunother. 2021 Aug;70(8):2223-2234. doi: 10.1007/s00262-020-02828-w. Epub 2021 Jan 23. Cancer Immunol Immunother. 2021. PMID: 33484295 Free PMC article.

10

Real-world survival outcomes with immune checkpoint inhibitors in large-cell neuroendocrine tumors of lung.

Dudnik E, Kareff S, Moskovitz M, Kim C, Liu SV, Lobachov A, Gottfried T, Urban D, Zer A, Rotem O, Onn A, Wollner M, Bar J; Israel Lung Cancer Group. Dudnik E, et al. Among authors: bar j. J Immunother Cancer. 2021 Feb;9(2):e001999. doi: 10.1136/jitc-2020-001999. J Immunother Cancer. 2021. PMID: 33597218 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

632 results

Search Page

Filters